tradingkey.logo

Viiv Healthcare’S Investigational Broadly Neutralising Antibody - N6ls - Successfully Maintains Viral Suppression In Long-Acting Treatment Of Hiv

ReutersMar 12, 2025 5:08 PM

- ViiV Healthcare:

  • VIIV HEALTHCARE’S INVESTIGATIONAL BROADLY NEUTRALISING ANTIBODY - N6LS - SUCCESSFULLY MAINTAINS VIRAL SUPPRESSION IN LONG-ACTING TREATMENT OF HIV

  • VIIV HEALTHCARE: N6LS WAS ALSO WELL TOLERATED BY PARTICIPANTS

  • VIIV HEALTHCARE: EMBRACE STUDY TO CONTINUE INVESTIGATING COMBINATION OF N6LS DOSED AT SIX MONTHS WITH CAB LA

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI